Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 332-336

  Zubel, Angela ^a   Flechtenmacher, Christa ^b   Edler, Lutz ^a   Alonso, Angel ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ADAM9; CIN; Immunohistochemistry; SCC

Indexed keywords

ADAM 9 PROTEIN; EPITOPE; PARAFFIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; THERMAL CONDUCTIVITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

ADAM PROTEINS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 67549094635     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.05.005     Document Type: Article

References (31)

1. Moss M.L., White J.M., Lambert M.H., and Andrews R.C. TACE and other ADAM proteases as targets for drug discovery. Drug Discov. Today 6 (2001) 417-426
2. Murphy G. The ADAMS: signalling scissors in the tumour microenvironment. Nat. Cancer Rev. 8 (2008) 929-941
3. Grutzmann R.J., Luttges J., Sipos B., Ammerpohl O., Dobrowolski F., Alldinger I., et al. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br. J. Cancer 90 (2004) 1053-1058
4. Iacobuzio-Donahue C.A., Maitra A., Olsen M., Lowe A.W., van Heek N.T., Rosty C., et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162 (2003) 1151-1162
5. Shintani Y., Higashiyama S., Ohta M., Hirabayashi H., Yamamoto S., Yoshimasu T., et al. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res. 64 (2004) 4190-4196
6. Carl-McGrath S., Lendeckel U., Ebert M., Roessner A., and Rocken C. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int. J. Oncol. 26 (2005) 17-24
7. Fritzsche F.R., Wassermann K., Jung M., Tölle A., Kristiansen I., Lein M., et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 8 (2008) 179
8. Wolfsberg T.G., Straight P.D., Robyn L.G., Houvila A.P.J., Primakoff P., Myles D.G., et al. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 169 (1995) 378-383
9. Basbaum C.B., and Werb Z. Focalized proteolysis:spatial and temporal regulation of extracellular matrix degradation at the surface. Curr. Opin. Cell Biol. 8 (1996) 731-738
10. Nagase H. Matrix metalloproteinase. In: Hooper N. (Ed). Zinc Metalloproteinases in Health and Disease (1996), Taylor and Francis, London 153-204
11. Primakoff P., and Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16 (2000) 83-87
12. Manzetti S., McCulloch D.R., Herington A.C., and van der Spoel D. Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10. J. Comp. Mol. Design 17 (2003) 551-565
13. Seals D.F., and Courtneige S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17 (2003) 7-30
14. Mazzocca A., Coppari R., De Franco R., Cho J.Y., Libermann T.A., Pinzani M., et al. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 65 (2005) 4728-4738
15. Peduto L., Reuter V.E., Shaffer D.R., Scher H.I., and Blobel C.P. Critical function for ADAM9 in mouse prostate cancer. Cancer Res. 65 (2005) 9312-9319
16. McCulloch D.R., Harvey M., and Herington A.C. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol. Cell. Endocrinol. 167 (2000) 11-21
17. Le Pabic H., Bonnier D., Wewer U.M., Coutand A., Musso O., Baffet G., et al. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37 (2003) 1056-1066
18. O'Shea C., McKie N., Buggy Y., Duggan C., Hill A.D., McDermott E., et al. Expression of ADAM-9 mRNA and protein in human breast cancer. Int. J. Cancer 105 (2003) 754-761
19. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
20. Richart R.M. Cervical intraepithelial neoplasia. Pathol. Annu. 8 (1973) 301-328
21. Wright T.C., Kurman R.J., and Ferenchy A. Precancerous lesions of the cervix. In: Kurman R.J. (Ed). Blaustein's Pathology of the Female Genital Tract (2002), Springer Verlag, New York 253-325
22. Nuovo G.J., MacConnel P.B., Simsir A., Valea F., and French D.L. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55 (1995) 267-275
23. Tamakoshi K., Kikkawa F., Nawa A., Ishikawa H., Mizuno K., Tamakoshi A., et al. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer 76 (1995) 2565-2571
24. Brumer O., Böhmer G., Hollwitz B., Flemming P., Petry K.U., and Kühnle H. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation: an immunohistochemical study. Gynecol. Oncol. 84 (2002) 222-227
25. Garzetti G.G., Ciavattini A., Lucarini G., Poteri G., Romanici C., and Bigini G. The 72-kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement. Gynecol. Oncol. 60 (1996) 271-276
26. Rauvala M., Aglund K., Puistola U., Turpeenniemi-Hujanen T., Horvath G., Willén R., et al. Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression. Int. J. Gynecol. Cancer 16 (2006) 1297-1302
27. Huovila A.P.J., Almeida E.A.C., and White J.M. ADAMs and cell fusion. Curr. Opin. Cell Biol. 8 (1996) 692-699
28. Blobel C.P. Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF alpha and Notch. Cell 90 (1997) 589-592
29. Black R.A., and White J.M. ADAMs: focus on the protease domain. Curr. Opin. Cell Biol. 10 (1998) 654-659
30. van Hamont D., Bulten J., Shirango H., Melchers W.J.G., Massuger L.F.A.G., and de Wilde P.C.M. Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models. Carcinogenesis 29 (2008) 840-845
31. Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol. 12 (1993) 186-192